Immune Mediated Anemia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Immune Mediated Anemia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingEarly Phase 1

NCT07441525

UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases

This is a single-arm, open-label, investigator-initiated trial (IIT) designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD)…

China27 participantsStarted 2026-02-03

Treatment: CART Infusion

All recent trials (7 shown)

Active — Not RecruitingNot Applicable

NCT05985122

New Analytic Tools for aHUS and C3G Diagnosis

This protocol is part of a larger project, COMPRare (COMPlement-mediated Rare kidney diseases), which has been financed on behalf of the EJP RD (European Joint…

Italy180 participantsStarted 2023-07-01

Treatment: C3NEF assay

TerminatedPhase 2

NCT05502783

Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias

Background: People who have a blood stem cell transplant can sometimes develop cytopenia. This means that their levels of one or more types of blood cell, such…

United States1 participantsStarted 2023-03-10

Treatment: fostamatinib

Immune Mediated Anemia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases

All recent trials (7 shown)

New Analytic Tools for aHUS and C3G Diagnosis

Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases

All recent trials (7 shown)

New Analytic Tools for aHUS and C3G Diagnosis

Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias

Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenia…

Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders

Parvovirus B19 Infection in Hereditary Hemolytic Anemias Patients

Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major